medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2023-8-53-63medalphabet-3121Research ArticleСтатьиРоль омега ПНЖК в комплексной профилактике и лечении некоторых заболеваний кожиThe role of omega PUFAs in the complex prevention and treatment of certain skin diseaseshttps://orcid.org/0000-0002-3811-9459ПрокопенкоЕ. В.ProkopenkoE. V.

Прокопенко Елена Валерьевна, врач-эндокринолог, диетолог, ведущий менеджер проектов медицинского департамента

Москва

Prokopenko Elena V., endocrinologist, dietitian, Project Manager of Medical Department

Moscow

elvprokopenko@gmail.comhttps://orcid.org/0000-0002-4689-3591ОрловаС. В.OrlovaS. V.

Орлова Светлана Владимировна, д. м. н., проф., зав. кафедрой диетологии и клинической нутрициологии, главный научный сотрудник

Москва

Orlova Svetlana V., DM Sci (habil.), professor, head of Dept of Dietetics and Clinical Nutritiology, Chief Researcher

Moscow

orlova-sv@rudn.ruhttps://orcid.org/0000-0003-3220-0333НикитинаЕ. А.NikitinaE. A.

Никитина Елена Александровна, к. м. н., доцент кафедры диетологии и клинической нутрициологии, научный сотрудник

Москва

Nikitina Elena A., PhD Med, assistant professor of Dept of Dietetics and Clinical Nutritiology, Researcher

Moscow

nikitina-ea1@rudn.ruhttps://orcid.org/0000-0002-5203-1082ВодолазкаяА. Н.VodolazkayaA. N.

Водолазкая Ангелина Николаевна, врач-диетолог

Москва

Vodolazkaya Angelina N., dietitian

Moscow

drvodolazkaya@gmail.comhttps://orcid.org/0000-0002-0548-3414БалашоваН. В.BalashovaN. V.

Балашова Наталья Валерьевна, к. б. н., ассистент доцент кафедры диетологии и клинической нутрициологии

Москва

Balashova Natalya V., PhD Bio Sci, assistant of Dept of Dietetics and Clinical Nutritiology

Moscow

balashovaN77@mail.ruhttps://orcid.org/0000-0003-4749-731XПигареваЮ. А.PigarevaYu. A.

Пигарева Юлия Анатольевна, к. м. н., зав. отделением клинической диетологии

Москва

Pigareva Yulia A., PhD Med, head of Dept of Clinical Dietetics

Moscow

yupigareva@yandex.ruООО «ИНВИТРО»РоссияNational Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health RussiaRussian FederationФГАОУ ВО «Российский университет дружбы народов» (РУДН); ГБУЗ «Научно-практический центр детской психоневрологии Департамента здравоохранения г. Москвы»РоссияPeoples’ Friendship University of Russia; Scientific and Practical Center for Child Psychoneurology, Moscow Department of HealthRussian FederationАвстрийская клиника микронутриентной терапии BiogenaРоссия”INVITRO” Limited Liability CompanyRussian FederationФГАОУ ВО «Российский университет дружбы народов» (РУДН)РоссияPeoples’ Friendship University of RussiaRussian FederationГБУЗ «Городская клиническая больница имени В. В. Виноградова Департамента здравоохранения Москвы»РоссияCity Clinical Hospital n. a. V. V. VinogradovRussian Federation20231406202308«Диетология и нутрициология» (1)5363Copyright © Прокопенко Е.В., Орлова С.В., Никитина Е.А., Водолазкая А.Н., Балашова Н.В., Пигарева Ю.А., 20232023Прокопенко Е.В., Орлова С.В., Никитина Е.А., Водолазкая А.Н., Балашова Н.В., Пигарева Ю.А.Prokopenko E.V., Orlova S.V., Nikitina E.A., Vodolazkaya A.N., Balashova N.V., Pigareva Y.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3121

Растущее количество данных о питании показывает, что мы действительно «то, что мы едим», и содержание жирных кислот в нашем рационе имеет далеко идущие физиологические последствия, многие из которых мы только начинаем понимать. Разнообразие жирных кислот присутствует в рационе человека, в кровотоке человека, а также в клетках и тканях человека. Жирные кислоты являются источниками энергии и составляющими мембран. Они обладают биологической активностью, которая влияет на клеточный и тканевой метаболизм, функцию и реакцию, на гормональные и другие сигналы. Благодаря этим эффектам жирные кислоты влияют на здоровье, самочувствие и риски заболеваний. Хотя традиционно наибольший интерес к влиянию жирных кислот на здоровье связан с сердечнососудистыми заболеваниями, метаболическими заболеваниями, такими как диабет 2 типа, воспалительными заболеваниями, нарушениями репродуктивной и нейрокогнитивной функций человека, теперь очевидно, что жирные кислоты влияют и на ряд других заболеваний, в том числе заболеваний кожи, включая атопический дерматит, псориаз, розацеа, акне.

A growing body of nutritional evidence shows that we are indeed «what we eat» and the fatty acid content of our diet has far-reaching physiological implications, many of which we are only just beginning to understand. A variety of fatty acids are present in the human diet, in the human bloodstream, and in human cells and tissues. Fatty acids are energy sources and components of membranes. They have biological activities that affect cellular and tissue metabolism, function and response, hormonal and other signals. Through these effects, fatty acids affect health, well-being, and disease risk. While the health effects of fatty acids have traditionally been of greatest interest in cardiovascular disease, metabolic diseases such as diabetes, inflammatory diseases, and reproductive and neurocognitive disorders, it is now clear that fatty acids are also involved in a number of other diseases, including skin diseases, atopic dermatitis, psoriasis, rosacea, acne.

полиненасыщенные жирные кислотыэйкозапентаеновая кислотадокозагексаеновая кислотагамма-линоленовая кислотазаболевания кожиатопический дерматитпсориазрозацеаакнеpolyunsaturated fatty acidseicosapentaenoic aciddocosahexaenoic acidgamma-linolenic acidskin diseasesatopic dermatitispsoriasisrosaceaacneReferencesBazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014 Dec;15(12):771–85. DOI: 10.1038/nrn3820Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014 Dec;15(12):771–85. DOI: 10.1038/nrn3820Abbott SK, Else PL, Atkins TA, Hulbert AJ. Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. Biochim. Biophys. Acta. 2012 May;1818(5):1309–17. DOI: 10.1016/j.bbamem.2012.01.011Abbott SK, Else PL, Atkins TA, Hulbert AJ. Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. Biochim. Biophys. Acta. 2012 May;1818(5):1309–17. DOI: 10.1016/j.bbamem.2012.01.011Sakai C, Ishida M, Ohba H, Yamashita H, Uchida H, Yoshizumi M, Ishida T. Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells. PLoS One. 2017 Nov 9;12(11): e0187934. DOI: 10.1371/journal.pone.0187934Sakai C, Ishida M, Ohba H, Yamashita H, Uchida H, Yoshizumi M, Ishida T. Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells. PLoS One. 2017 Nov 9;12(11): e0187934. DOI: 10.1371/journal.pone.0187934Oppedisano F, Macrì R, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Bosco F, Nucera S, Caterina Zito M, Guarnieri L, Scarano F, Nicita C, Coppoletta AR, Ruga S, Scicchitano M, Mollace R, Palma E, Mollace V. The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection. Biomedicines. 2020 Aug 25;8(9):306. DOI: 10.3390/biomedicines8090306Oppedisano F, Macrì R, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Bosco F, Nucera S, Caterina Zito M, Guarnieri L, Scarano F, Nicita C, Coppoletta AR, Ruga S, Scicchitano M, Mollace R, Palma E, Mollace V. The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection. Biomedicines. 2020 Aug 25;8(9):306. DOI: 10.3390/biomedicines8090306Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta. 2015 Apr;1851(4):469–84. DOI: 10.1016/j.bbalip.2014.08.010Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta. 2015 Apr;1851(4):469–84. DOI: 10.1016/j.bbalip.2014.08.010Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem. Soc. Trans. 2017 Oct 15;45(5):1105–1115. DOI: 10.1042/BST20160474Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem. Soc. Trans. 2017 Oct 15;45(5):1105–1115. DOI: 10.1042/BST20160474Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry. 2020 Feb 28;11:122. DOI: 10.3389/fpsyt.2020.00122Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry. 2020 Feb 28;11:122. DOI: 10.3389/fpsyt.2020.00122Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis. 2009 Aug;205(2):538–43. DOI: 10.1016/j.atherosclerosis.2008.12.013Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis. 2009 Aug;205(2):538–43. DOI: 10.1016/j.atherosclerosis.2008.12.013Fontes JD, Rahman F, Lacey S, Larson MG, Vasan RS, Benjamin EJ, Harris WS, Robins SJ. Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis. 2015 Jun;240(2):431–6. DOI: 10.1016/j.atherosclerosis.2015.03.043Fontes JD, Rahman F, Lacey S, Larson MG, Vasan RS, Benjamin EJ, Harris WS, Robins SJ. Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis. 2015 Jun;240(2):431–6. DOI: 10.1016/j.atherosclerosis.2015.03.043Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J. Vasc. Surg. 2013 Nov;58(5):1283–90. DOI: 10.1016/j.jvs.2013.05.024Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J. Vasc. Surg. 2013 Nov;58(5):1283–90. DOI: 10.1016/j.jvs.2013.05.024AbuMweis S, Jew S, Tayyem R, Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J. Hum. Nutr. Diet. 2018 Feb;31(1):67–84. DOI: 10.1111/jhn.12493AbuMweis S, Jew S, Tayyem R, Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J. Hum. Nutr. Diet. 2018 Feb;31(1):67–84. DOI: 10.1111/jhn.12493Lin N, Shi JJ, Li YM, Zhang XY, Chen Y, Calder PC, Tang LJ. What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2016 Aug 20;15:133. DOI: 10.1186/s12944–016–0303–7Lin N, Shi JJ, Li YM, Zhang XY, Chen Y, Calder PC, Tang LJ. What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2016 Aug 20;15:133. DOI: 10.1186/s12944–016–0303–7O’Mahoney LL, Matu J, Price OJ, Birch KM, Ajjan RA, Farrar D, Tapp R, West DJ, Deighton K, Campbell MD. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc. Diabetol. 2018 Jul 7;17(1):98. DOI: 10.1186/s12933–018–0740-xO’Mahoney LL, Matu J, Price OJ, Birch KM, Ajjan RA, Farrar D, Tapp R, West DJ, Deighton K, Campbell MD. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc. Diabetol. 2018 Jul 7;17(1):98. DOI: 10.1186/s12933–018–0740-xLee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001 May 18;276(20):16683–9. DOI: 10.1074/jbc.M011695200Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001 May 18;276(20):16683–9. DOI: 10.1074/jbc.M011695200Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR 4. J. Immunol. 2005 May 1;174(9):5390–7. DOI: 10.4049/jimmunol.174.9.5390Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR 4. J. Immunol. 2005 May 1;174(9):5390–7. DOI: 10.4049/jimmunol.174.9.5390Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009 Oct 2;284(40):27384–92. DOI: 10.1074/jbc.M109.044065Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009 Oct 2;284(40):27384–92. DOI: 10.1074/jbc.M109.044065Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR 120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010 Sep 3;142(5):687–98. DOI: 10.1016/j.cell.2010.07.041Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR 120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010 Sep 3;142(5):687–98. DOI: 10.1016/j.cell.2010.07.041Im DS. FFA4 (GPR 120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation. Mol. Aspects Med. 2018 Dec;64:92–108. DOI: 10.1016/j.mam.2017.09.001Im DS. FFA4 (GPR 120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation. Mol. Aspects Med. 2018 Dec;64:92–108. DOI: 10.1016/j.mam.2017.09.001Fan R, Koehler K, Chung S. Adaptive thermogenesis by dietary n-3 polyunsaturated fatty acids: Emerging evidence and mechanisms. Biochim Biophys Acta. Mol. Cell Biol. Lipids. 2019 Jan;1864(1):59–70. DOI: 10.1016/j.bbalip.2018.04.012Fan R, Koehler K, Chung S. Adaptive thermogenesis by dietary n-3 polyunsaturated fatty acids: Emerging evidence and mechanisms. Biochim Biophys Acta. Mol. Cell Biol. Lipids. 2019 Jan;1864(1):59–70. DOI: 10.1016/j.bbalip.2018.04.012Brown LH, Mutch DM. Mechanisms underlying N 3-PUFA regulation of white adipose tissue endocrine function. Curr. Opin. Pharmacol. 2020 Jun;52:40–46. DOI: 10.1016/j.coph.2020.04.009Brown LH, Mutch DM. Mechanisms underlying N 3-PUFA regulation of white adipose tissue endocrine function. Curr. Opin. Pharmacol. 2020 Jun;52:40–46. DOI: 10.1016/j.coph.2020.04.009López-Vicario C, Rius B, Alcaraz-Quiles J, García-Alonso V, Lopategi A, Titos E, Clària J. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. Eur. J. Pharmacol. 2016 Aug 15;785:133–143. DOI: 10.1016/j.ejphar.2015.03.092López-Vicario C, Rius B, Alcaraz-Quiles J, García-Alonso V, Lopategi A, Titos E, Clària J. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. Eur. J. Pharmacol. 2016 Aug 15;785:133–143. DOI: 10.1016/j.ejphar.2015.03.092Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J. Clin. Invest. 2018 Jul 2;128(7):2657–2669. DOI: 10.1172/JCI97943Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J. Clin. Invest. 2018 Jul 2;128(7):2657–2669. DOI: 10.1172/JCI97943Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol. Aspects Med. 2017 Dec;58:1–11. DOI: 10.1016/j.mam.2017.03.001Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol. Aspects Med. 2017 Dec;58:1–11. DOI: 10.1016/j.mam.2017.03.001Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002 Oct 21;196(8):1025–37. DOI: 10.1084/jem.20020760Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002 Oct 21;196(8):1025–37. DOI: 10.1084/jem.20020760Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E 1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 2010 Jan 29;285(5):3451–61. DOI: 10.1074/jbc.M109.044131Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E 1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 2010 Jan 29;285(5):3451–61. DOI: 10.1074/jbc.M109.044131Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE 1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006 Feb;20(2):401–3. DOI: 10.1096/fj.05–4724fjeHasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE 1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006 Feb;20(2):401–3. DOI: 10.1096/fj.05–4724fjeAriel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007 Apr;28(4):176–83. DOI: 10.1016/j.it.2007.02.007Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007 Apr;28(4):176–83. DOI: 10.1016/j.it.2007.02.007Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011 Oct 12;111(10):5922–43. DOI: 10.1021/cr100396cSerhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011 Oct 12;111(10):5922–43. DOI: 10.1021/cr100396cWeylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012 Mar;97(3–4):73–82. DOI: 10.1016/j.prostaglandins.2012.01.005Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012 Mar;97(3–4):73–82. DOI: 10.1016/j.prostaglandins.2012.01.005Sawada Y, Honda T, Nakamizo S, Otsuka A, Ogawa N, Kobayashi Y, Nakamura M, Kabashima K. Resolvin E 1 attenuates murine psoriatic dermatitis. Sci. Rep. 2018 Aug 8;8(1):11873. DOI: 10.1038/s41598–018–30373–1Sawada Y, Honda T, Nakamizo S, Otsuka A, Ogawa N, Kobayashi Y, Nakamura M, Kabashima K. Resolvin E 1 attenuates murine psoriatic dermatitis. Sci. Rep. 2018 Aug 8;8(1):11873. DOI: 10.1038/s41598–018–30373–1Else PL, Hulbert AJ. Membranes as metabolic pacemakers. Clin. Exp. Pharmacol. Physiol. 2003 Aug;30(8):559–64. DOI: 10.1046/j.1440–1681.2003.03883.xElse PL, Hulbert AJ. Membranes as metabolic pacemakers. Clin. Exp. Pharmacol. Physiol. 2003 Aug;30(8):559–64. DOI: 10.1046/j.1440–1681.2003.03883.xRabionet M, Gorgas K, Sandhoff R. Ceramide synthesis in the epidermis. Biochim. Biophys. Acta. 2014 Mar;1841(3):422–34. DOI: 10.1016/j.bbalip.2013.08.011Rabionet M, Gorgas K, Sandhoff R. Ceramide synthesis in the epidermis. Biochim. Biophys. Acta. 2014 Mar;1841(3):422–34. DOI: 10.1016/j.bbalip.2013.08.011Uchida Y, Hamanaka S: Stratum cormeum ceramides: Function, origins, and therapeutic implications. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, p. 43.Uchida Y, Hamanaka S: Stratum cormeum ceramides: Function, origins, and therapeutic implications. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, p. 43.Bouwstra JA, Pilgrim K, Ponec M: Structure of the skin barrier. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, p. 65.Bouwstra JA, Pilgrim K, Ponec M: Structure of the skin barrier. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, p. 65.Marekov LN, Steinert PM. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J. Biol. Chem. 1998 Jul 10;273(28):17763–70. DOI: 10.1074/jbc.273.28.17763Marekov LN, Steinert PM. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J. Biol. Chem. 1998 Jul 10;273(28):17763–70. DOI: 10.1074/jbc.273.28.17763Swartzendruber DC, Wertz PW, Madison KC, Downing DT. Evidence that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol. 1987 Jun;88(6):709–13. DOI: 10.1111/1523–1747.ep12470383Swartzendruber DC, Wertz PW, Madison KC, Downing DT. Evidence that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol. 1987 Jun;88(6):709–13. DOI: 10.1111/1523–1747.ep12470383Wertz PW: Biochemistry of human stratum corneum lipids. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, pp. 33–42.Wertz PW: Biochemistry of human stratum corneum lipids. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor and Francis, 2006, pp. 33–42.Balić A, Vlašić D, Žužul K, Marinović B, Bukvić Mokos Z. Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases. Int J. Mol. Sci. 2020 Jan 23;21(3):741. DOI: 10.3390/ijms21030741Balić A, Vlašić D, Žužul K, Marinović B, Bukvić Mokos Z. Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases. Int J. Mol. Sci. 2020 Jan 23;21(3):741. DOI: 10.3390/ijms21030741Feingold KR. The outer frontier: the importance of lipid metabolism in the skin. J. Lipid Res. 2009 Apr;50 Suppl(Suppl): S 417–22. DOI: 10.1194/jlr.R 800039-JLR 200Feingold KR. The outer frontier: the importance of lipid metabolism in the skin. J. Lipid Res. 2009 Apr;50 Suppl(Suppl): S 417–22. DOI: 10.1194/jlr.R 800039-JLR 200McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin. Dermatol. 2010 Jul-Aug;28(4):440–51. DOI: 10.1016/j.clindermatol.2010.03.020McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin. Dermatol. 2010 Jul-Aug;28(4):440–51. DOI: 10.1016/j.clindermatol.2010.03.020Harnack K, Andersen G, Somoza V. Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutr. Metab. (Lond). 2009 Feb 19;6:8. DOI: 10.1186/1743–7075–6–8Harnack K, Andersen G, Somoza V. Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutr. Metab. (Lond). 2009 Feb 19;6:8. DOI: 10.1186/1743–7075–6–8Akiyama M. The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation. Biochim. Biophys. Acta. 2014 Mar;1841(3):435–40. DOI: 10.1016/j.bbalip.2013.08.009Akiyama M. The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation. Biochim. Biophys. Acta. 2014 Mar;1841(3):435–40. DOI: 10.1016/j.bbalip.2013.08.009Hovnanian A. Harlequin ichthyosis unmasked: a defect of lipid transport. J. Clin. Invest. 2005 Jul;115(7):1708–10. DOI: 10.1172/JCI25736Hovnanian A. Harlequin ichthyosis unmasked: a defect of lipid transport. J. Clin. Invest. 2005 Jul;115(7):1708–10. DOI: 10.1172/JCI25736Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J. Clin. Invest. 1990 Mar;85(3):874–82. DOI: 10.1172/JCI114514Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J. Clin. Invest. 1990 Mar;85(3):874–82. DOI: 10.1172/JCI114514Schneider MR, Paus R. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J. Biochem. Cell. Biol. 2010 Feb;42(2):181–5. DOI: 10.1016/j.biocel.2009.11.017Schneider MR, Paus R. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J. Biochem. Cell. Biol. 2010 Feb;42(2):181–5. DOI: 10.1016/j.biocel.2009.11.017Fluhr JW, Mao-Qiang M, Brown BE, Wertz PW, Crumrine D, Sundberg JP, Feingold KR, Elias PM. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J. Invest. Dermatol. 2003 May;120(5):728–37. DOI: 10.1046/j.1523–1747.2003.12134.xFluhr JW, Mao-Qiang M, Brown BE, Wertz PW, Crumrine D, Sundberg JP, Feingold KR, Elias PM. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J. Invest. Dermatol. 2003 May;120(5):728–37. DOI: 10.1046/j.1523–1747.2003.12134.xDrake DR, Brogden KA, Dawson DV, Wertz PW. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid. Res. 2008 Jan;49(1):4–11. DOI: 10.1194/jlr.R 700016-JLR 200Drake DR, Brogden KA, Dawson DV, Wertz PW. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid. Res. 2008 Jan;49(1):4–11. DOI: 10.1194/jlr.R 700016-JLR 200Mauro T. SC pH: measurement origins, and functions. In Skin Barrier. P. Elias, and K. Feingold. Taylor & Francis, New York2006: 223–229.Mauro T. SC pH: measurement origins, and functions. In Skin Barrier. P. Elias, and K. Feingold. Taylor & Francis, New York2006: 223–229.Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007 Apr;29(1):3– 14. DOI: 10.1007/s00281–007–0060–9Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007 Apr;29(1):3– 14. DOI: 10.1007/s00281–007–0060–9Radek K, Gallo R. Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol. 2007 Apr;29(1):27–43. DOI: 10.1007/s00281–007–0064–5Radek K, Gallo R. Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol. 2007 Apr;29(1):27–43. DOI: 10.1007/s00281–007–0064–5Leung DY: New insights into the complex gene-environment interactions evolving into atopic dermatitis. J. Allergy. Clin. Immunol. 2006;118(1):37. DOI: 10.1016/j.jaci.2006.04.045Leung DY: New insights into the complex gene-environment interactions evolving into atopic dermatitis. J. Allergy. Clin. Immunol. 2006;118(1):37. DOI: 10.1016/j.jaci.2006.04.045Elias PM, Feingold KR. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch. Dermatol. 2001 Aug;137(8):1079–81. PMID: 11493102.Elias PM, Feingold KR. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch. Dermatol. 2001 Aug;137(8):1079–81. PMID: 11493102.Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin. Dermatol. 2003 Mar-Apr;21(2):134–44. DOI: 10.1016/s0738–081x(02)00370-xProksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin. Dermatol. 2003 Mar-Apr;21(2):134–44. DOI: 10.1016/s0738–081x(02)00370-xProksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci. 2006 Sep;43(3):159–69. DOI: 10.1016/j.jdermsci.2006.06.003Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci. 2006 Sep;43(3):159–69. DOI: 10.1016/j.jdermsci.2006.06.003Proksch E, Fölster-Holst R, Bräutigam M, Sepehrmanesh M, Pfeiffer S, Jensen JM. Role of the epidermal barrier in atopic dermatitis. J. Dtsch. Dermatol. Ges. 2009 Oct;7(10):899–910. English, German. DOI: 10.1111/j.1610–0387.2009.07157.xProksch E, Fölster-Holst R, Bräutigam M, Sepehrmanesh M, Pfeiffer S, Jensen JM. Role of the epidermal barrier in atopic dermatitis. J. Dtsch. Dermatol. Ges. 2009 Oct;7(10):899–910. English, German. DOI: 10.1111/j.1610–0387.2009.07157.xBurr GO, Burr MM. Nutrition classics from The Journal of Biological Chemistry 82:345–67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr. Rev. 1973 Aug;31(8):248–9. DOI: 10.1111/j.1753–4887.1973.tb06008.xBurr GO, Burr MM. Nutrition classics from The Journal of Biological Chemistry 82:345–67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr. Rev. 1973 Aug;31(8):248–9. DOI: 10.1111/j.1753–4887.1973.tb06008.xBurr, G.O.; Burr, M. M. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 1930;86:587–621.Burr, G.O.; Burr, M. M. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 1930;86:587–621.Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, Cogen AL, Gallo RL. TLR 2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J. Invest. Dermatol. 2011 Mar;131(3):688–97. DOI: 10.1038/jid.2010.351Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, Cogen AL, Gallo RL. TLR 2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J. Invest. Dermatol. 2011 Mar;131(3):688–97. DOI: 10.1038/jid.2010.351Deng Z, Chen M, Liu Y, Xu S, Ouyang Y, Shi W, Jian D, Wang B, Liu F, Li J, Shi Q, Peng Q, Sha K, Xiao W, Liu T, Zhang Y, Zhang H, Wang Q, Sun L, Xie H, Li J. A positive feedback loop between mTORC 1 and cathelicidin promotes skin inflammation in rosacea. EMBO Mol. Med. 2021 May 7;13(5): e13560. DOI: 10.15252/emmm.202013560Deng Z, Chen M, Liu Y, Xu S, Ouyang Y, Shi W, Jian D, Wang B, Liu F, Li J, Shi Q, Peng Q, Sha K, Xiao W, Liu T, Zhang Y, Zhang H, Wang Q, Sun L, Xie H, Li J. A positive feedback loop between mTORC 1 and cathelicidin promotes skin inflammation in rosacea. EMBO Mol. Med. 2021 May 7;13(5): e13560. DOI: 10.15252/emmm.202013560Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother. 2002 Oct;56(8):388–96. DOI: 10.1016/s0753–3322(02)00256–1Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother. 2002 Oct;56(8):388–96. DOI: 10.1016/s0753–3322(02)00256–1Li G, Tang X, Zhang S, Deng Z, Wang B, Shi W, Xie H, Liu B, Li J. Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2-NF-κB Signaling. J. Invest. Dermatol. 2022 Oct;142(10):2580–2590.e6. DOI: 10.1016/j.jid.2022.03.026Li G, Tang X, Zhang S, Deng Z, Wang B, Shi W, Xie H, Liu B, Li J. Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2-NF-κB Signaling. J. Invest. Dermatol. 2022 Oct;142(10):2580–2590.e6. DOI: 10.1016/j.jid.2022.03.026Elias P. M., Feingold K. R., Fartasch M. The epidermal lamellar body as a multifunctional secretory organelle. In Skin Barrier; Elias, P.M., Feingold, K.R., Eds.; CRC Press: Boca Raton, FL, USA, 2005; pp. 281–292.Elias P. M., Feingold K. R., Fartasch M. The epidermal lamellar body as a multifunctional secretory organelle. In Skin Barrier; Elias, P.M., Feingold, K.R., Eds.; CRC Press: Boca Raton, FL, USA, 2005; pp. 281–292.Mueller M, Lukas B, Novak J, Simoncini T, Genazzani AR, Jungbauer A. Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J. Agric. Food. Chem. 2008 Dec 24;56(24):11621–30. DOI: 10.1021/jf802298wMueller M, Lukas B, Novak J, Simoncini T, Genazzani AR, Jungbauer A. Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J. Agric. Food. Chem. 2008 Dec 24;56(24):11621–30. DOI: 10.1021/jf802298wZhou XR, Sun CH, Liu JR, Zhao D. Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res. 2008 Oct;18(5):361–368. DOI: 10.1016/j.ghir.2008.01.001Zhou XR, Sun CH, Liu JR, Zhao D. Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res. 2008 Oct;18(5):361–368. DOI: 10.1016/j.ghir.2008.01.001Lima Ede A, Lima MM, Marques CD, Duarte AL, Pita Ida R, Pita MG. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis. An Bras. Dermatol. 2013 Nov-Dec;88(6):1029–35. DOI: 10.1590/abd1806–4841.20132653Lima Ede A, Lima MM, Marques CD, Duarte AL, Pita Ida R, Pita MG. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis. An Bras. Dermatol. 2013 Nov-Dec;88(6):1029–35. DOI: 10.1590/abd1806–4841.20132653Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC, Chi Y, Kurtz TW. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch. Dermatol. 2000 May;136(5):609–16. DOI: 10.1001/archderm.136.5.609Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC, Chi Y, Kurtz TW. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch. Dermatol. 2000 May;136(5):609–16. DOI: 10.1001/archderm.136.5.609Hanley K, Kömüves LG, Bass NM, He SS, Jiang Y, Crumrine D, Appel R, Friedman M, Bettencourt J, Min K, Elias PM, Williams ML, Feingold KR. Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators. J. Invest. Dermatol. 1999 Nov;113(5):788–95. DOI: 10.1046/j.1523–1747.1999.00743.xHanley K, Kömüves LG, Bass NM, He SS, Jiang Y, Crumrine D, Appel R, Friedman M, Bettencourt J, Min K, Elias PM, Williams ML, Feingold KR. Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators. J. Invest. Dermatol. 1999 Nov;113(5):788–95. DOI: 10.1046/j.1523–1747.1999.00743.xBongartz T, Coras B, Vogt T, Schölmerich J, Müller-Ladner U. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford). 2005 Jan;44(1):126–9. DOI: 10.1093/rheumatology/keh423Bongartz T, Coras B, Vogt T, Schölmerich J, Müller-Ladner U. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford). 2005 Jan;44(1):126–9. DOI: 10.1093/rheumatology/keh423Foster RH, Hardy G, Alany RG. Borage oil in the treatment of atopic dermatitis. Nutrition. 2010 Jul-Aug;26(7–8):708–18. DOI: 10.1016/j.nut.2009.10.014Foster RH, Hardy G, Alany RG. Borage oil in the treatment of atopic dermatitis. Nutrition. 2010 Jul-Aug;26(7–8):708–18. DOI: 10.1016/j.nut.2009.10.014Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol. 2002 Jul;119(1):166–73. DOI: 10.1046/j.1523–1747.2002.01833.xMacheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol. 2002 Jul;119(1):166–73. DOI: 10.1046/j.1523–1747.2002.01833.xFartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br. J. Dermatol. 1992 Sep;127(3):221–7. DOI: 10.1111/ j.1365–2133.1992.tb00118.xFartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br. J. Dermatol. 1992 Sep;127(3):221–7. DOI: 10.1111/ j.1365–2133.1992.tb00118.xGuttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr. Opin. Immunol. 2017 Oct;48:68–73. DOI: 10.1016/j.coi.2017.08.008Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr. Opin. Immunol. 2017 Oct;48:68–73. DOI: 10.1016/j.coi.2017.08.008Ferreri C, Angelini F, Chatgilialoglu C, Dellonte S, Moschese V, Rossi P, Chini L. Trans fatty acids and atopic eczema/dermatitis syndrome: the relationship with a free radical cis-trans isomerization of membrane lipids. Lipids. 2005 Jul;40(7):661–7. DOI: 10.1007/s11745–005–1428–7Ferreri C, Angelini F, Chatgilialoglu C, Dellonte S, Moschese V, Rossi P, Chini L. Trans fatty acids and atopic eczema/dermatitis syndrome: the relationship with a free radical cis-trans isomerization of membrane lipids. Lipids. 2005 Jul;40(7):661–7. DOI: 10.1007/s11745–005–1428–7Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004 Apr;79(4):674–81. DOI: 10.1093/ajcn/79.4.674Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004 Apr;79(4):674–81. DOI: 10.1093/ajcn/79.4.674Huang TH, Wang PW, Yang SC, Chou WL, Fang JY. Cosmetic and Therapeutic Applications of Fish Oil’s Fatty Acids on the Skin. Mar Drugs. 2018 Jul 30;16(8):256. DOI: 10.3390/md16080256Huang TH, Wang PW, Yang SC, Chou WL, Fang JY. Cosmetic and Therapeutic Applications of Fish Oil’s Fatty Acids on the Skin. Mar Drugs. 2018 Jul 30;16(8):256. DOI: 10.3390/md16080256Honda T, Kabashima K. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis. Int Immunol. 2019 Aug 23;31(9):589–595. DOI: 10.1093/intimm/dxy087Honda T, Kabashima K. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis. Int Immunol. 2019 Aug 23;31(9):589–595. DOI: 10.1093/intimm/dxy087Calder PC. Eicosanoids. Essays Biochem. 2020 Sep 23;64(3):423–441. DOI: 10.1042/EBC 20190083Calder PC. Eicosanoids. Essays Biochem. 2020 Sep 23;64(3):423–441. DOI: 10.1042/EBC 20190083Sergeant S, Rahbar E, Chilton FH. Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. Eur. J. Pharmacol. 2016 Aug 15;785:77–86. DOI: 10.1016/j.ejphar.2016.04.020Sergeant S, Rahbar E, Chilton FH. Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. Eur. J. Pharmacol. 2016 Aug 15;785:77–86. DOI: 10.1016/j.ejphar.2016.04.020Mir, M. Echium Oil: A Valuable Source of n-3 and n-6 Fatty Acids. OCL 2008;15:252–256. DOI: 10.1051/ocl.2008.0203Mir, M. Echium Oil: A Valuable Source of n-3 and n-6 Fatty Acids. OCL 2008;15:252–256. DOI: 10.1051/ocl.2008.0203Koch C, Dölle S, Metzger M, Rasche C, Jungclas H, Rühl R, Renz H, Worm M. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br. J. Dermatol. 2008 Apr;158(4):786–92. DOI: 10.1111/j.1365–2133.2007.08430.xKoch C, Dölle S, Metzger M, Rasche C, Jungclas H, Rühl R, Renz H, Worm M. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br. J. Dermatol. 2008 Apr;158(4):786–92. DOI: 10.1111/j.1365–2133.2007.08430.xGreb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat. Rev. Dis. Primers. 2016 Nov 24;2:16082. DOI: 10.1038/nrdp.2016.82Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat. Rev. Dis. Primers. 2016 Nov 24;2:16082. DOI: 10.1038/nrdp.2016.82Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 2010 May;130(5):1373–83. DOI: 10.1038/jid.2009.399Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 2010 May;130(5):1373–83. DOI: 10.1038/jid.2009.399Barrea L, Balato N, Di Somma C, Macchia PE, Napolitano M, Savanelli MC, Esposito K, Colao A, Savastano S. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J. Transl. Med. 2015 Jan 27;13:18. DOI: 10.1186/s12967–014–0372–1Barrea L, Balato N, Di Somma C, Macchia PE, Napolitano M, Savanelli MC, Esposito K, Colao A, Savastano S. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J. Transl. Med. 2015 Jan 27;13:18. DOI: 10.1186/s12967–014–0372–1Duarte GV, Follador I, Cavalheiro CM, Silva TS, Oliveira Mde F. Psoriasis and obesity: literature review and recommendations for management. An Bras. Dermatol. 2010 May-Jun;85(3):355–60. English, Portuguese. DOI: 10.1590/s0365–05962010000300009Duarte GV, Follador I, Cavalheiro CM, Silva TS, Oliveira Mde F. Psoriasis and obesity: literature review and recommendations for management. An Bras. Dermatol. 2010 May-Jun;85(3):355–60. English, Portuguese. DOI: 10.1590/s0365–05962010000300009Li SS, Liu Y, Li H, Wang LP, Xue LF, Yin GS, Wu XS. Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS. Eur. Rev. Med. Pharmacol Sci. 2019 May;23(9):3940–3950. DOI: 10.26355/eurrev_201905_17823Li SS, Liu Y, Li H, Wang LP, Xue LF, Yin GS, Wu XS. Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS. Eur. Rev. Med. Pharmacol Sci. 2019 May;23(9):3940–3950. DOI: 10.26355/eurrev_201905_17823Namazi MR. Why is psoriasis uncommon in Africans? The influence of dietary factors on the expression of psoriasis. Int J. Dermatol. 2004 May;43(5):391–2. DOI: 10.1111/j.1365–4632.2004.02126.xNamazi MR. Why is psoriasis uncommon in Africans? The influence of dietary factors on the expression of psoriasis. Int J. Dermatol. 2004 May;43(5):391–2. DOI: 10.1111/j.1365–4632.2004.02126.xHorrobin DF. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med. Hypotheses. 1987 Apr;22(4):421–8. DOI: 10.1016/0306–9877(87)90037–5Horrobin DF. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med. Hypotheses. 1987 Apr;22(4):421–8. DOI: 10.1016/0306–9877(87)90037–5Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin. Dermatol. 2010 NovDec;28(6):615–26. DOI: 10.1016/j.clindermatol.2010.03.027Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin. Dermatol. 2010 NovDec;28(6):615–26. DOI: 10.1016/j.clindermatol.2010.03.027Gupta AK, Ellis CN, Goldfarb MT, Hamilton TA, Voorhees JJ. The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis. Int J. Dermatol. 1990 Oct;29(8):591–5. DOI: 10.1111/j.1365–4362.1990.tb03477.xGupta AK, Ellis CN, Goldfarb MT, Hamilton TA, Voorhees JJ. The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis. Int J. Dermatol. 1990 Oct;29(8):591–5. DOI: 10.1111/j.1365–4362.1990.tb03477.xArican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005 Oct 24;2005(5):273–9. DOI: 10.1155/MI.2005.273Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005 Oct 24;2005(5):273–9. DOI: 10.1155/MI.2005.273Upala S, Yong WC, Theparee T, Sanguankeo A. Effect of omega-3 fatty acids on disease severity in patients with psoriasis: A systematic review. Int J. Rheum. Dis. 2017 Apr;20(4):442–450. DOI: 10.1111/1756–185X.13051Upala S, Yong WC, Theparee T, Sanguankeo A. Effect of omega-3 fatty acids on disease severity in patients with psoriasis: A systematic review. Int J. Rheum. Dis. 2017 Apr;20(4):442–450. DOI: 10.1111/1756–185X.13051Clark CCT, Taghizadeh M, Nahavandi M, Jafarnejad S. Efficacy of ω-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin. Rheumatol. 2019 Apr;38(4):977–988. DOI: 10.1007/s10067–019–04456-xClark CCT, Taghizadeh M, Nahavandi M, Jafarnejad S. Efficacy of ω-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin. Rheumatol. 2019 Apr;38(4):977–988. DOI: 10.1007/s10067–019–04456-xAllen BR. Fish oil in combination with other therapies in the treatment of psoriasis. World Rev. Nutr. Diet. 1991;66:436–45. DOI: 10.1159/000419312Allen BR. Fish oil in combination with other therapies in the treatment of psoriasis. World Rev. Nutr. Diet. 1991;66:436–45. DOI: 10.1159/000419312Rossmeisl M, Jelenik T, Jilkova Z, Slamova K, Kus V, Hensler M, Medrikova D, Povysil C, Flachs P, Mohamed-Ali V, Bryhn M, Berge K, Holmeide AK, Kopecky J. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Obesity (Silver Spring). 2009 May;17(5):1023–31. DOI: 10.1038/oby.2008.602Rossmeisl M, Jelenik T, Jilkova Z, Slamova K, Kus V, Hensler M, Medrikova D, Povysil C, Flachs P, Mohamed-Ali V, Bryhn M, Berge K, Holmeide AK, Kopecky J. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Obesity (Silver Spring). 2009 May;17(5):1023–31. DOI: 10.1038/oby.2008.602Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br. J. Dermatol. 2013 Aug;169(2):266–82. DOI: 10.1111/bjd.12355Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br. J. Dermatol. 2013 Aug;169(2):266–82. DOI: 10.1111/bjd.12355Liu M, Li X, Chen XY, Xue F, Zheng J. Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial. Dermatol Ther. 2015 Nov-Dec;28(6):373–82. DOI: 10.1111/dth.12259.Liu M, Li X, Chen XY, Xue F, Zheng J. Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial. Dermatol Ther. 2015 Nov-Dec;28(6):373–82. DOI: 10.1111/dth.12259.Evidence suggests rosacea may be linked to Parkinson’s and Alzheimer’s disease. Nurs. Stand. 2016 May 25;30(39):14. DOI: 10.7748/ns.30.39.14.s16Evidence suggests rosacea may be linked to Parkinson’s and Alzheimer’s disease. Nurs. Stand. 2016 May 25;30(39):14. DOI: 10.7748/ns.30.39.14.s16Yuan X, Li J, Li Y, Deng Z, Zhou L, Long J, Tang Y, Zuo Z, Zhang Y, Xie H. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea. Biomed. Pharmacother. 2019 Sep;117:109181. DOI: 10.1016/j.biopha.2019.109181Yuan X, Li J, Li Y, Deng Z, Zhou L, Long J, Tang Y, Zuo Z, Zhang Y, Xie H. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea. Biomed. Pharmacother. 2019 Sep;117:109181. DOI: 10.1016/j.biopha.2019.109181Li J, Yuan X, Tang Y, Wang B, Deng Z, Huang Y, Liu F, Zhao Z, Zhang Y. Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol. 2020 Feb;79:106178. DOI: 10.1016/j.intimp.2019.106178Li J, Yuan X, Tang Y, Wang B, Deng Z, Huang Y, Liu F, Zhao Z, Zhang Y. Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol. 2020 Feb;79:106178. DOI: 10.1016/j.intimp.2019.106178Wang L, Wang YJ, Hao D, Wen X, Du D, He G, Jiang X. The Theranostics Role of Mast Cells in the Pathophysiology of Rosacea. Front Med. (Lausanne). 2020 Jan 28;6:324. DOI: 10.3389/fmed.2019.00324Wang L, Wang YJ, Hao D, Wen X, Du D, He G, Jiang X. The Theranostics Role of Mast Cells in the Pathophysiology of Rosacea. Front Med. (Lausanne). 2020 Jan 28;6:324. DOI: 10.3389/fmed.2019.00324van den Elsen L, Garssen J, Willemsen L. Long chain N-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease. Curr Pharm Des. 2012;18(16):2375–92. DOI: 10.2174/138161212800165960van den Elsen L, Garssen J, Willemsen L. Long chain N-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease. Curr Pharm Des. 2012;18(16):2375–92. DOI: 10.2174/138161212800165960Nishi K, Kanayama Y, Kim IH, Nakata A, Nishiwaki H, Sugahara T. Docosahexaenoyl ethanolamide mitigates IgE-mediated allergic reactions by inhibiting mast cell degranulation and regulating allergy-related immune cells. Sci. Rep. 2019 Nov 7;9(1):16213. DOI: 10.1038/s41598–019–52317-zNishi K, Kanayama Y, Kim IH, Nakata A, Nishiwaki H, Sugahara T. Docosahexaenoyl ethanolamide mitigates IgE-mediated allergic reactions by inhibiting mast cell degranulation and regulating allergy-related immune cells. Sci. Rep. 2019 Nov 7;9(1):16213. DOI: 10.1038/s41598–019–52317-zZeng Q, Yang J, Yan G, Zhang L, Wang P, Zhang H, Chen Q, Cao Y, Liu X, Wang X. Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+/CaMKII-mTOR-NF-κB activation. Biomed. Pharmacother. 2022 Sep;153:113292. DOI: 10.1016/j.biopha.2022.113292Zeng Q, Yang J, Yan G, Zhang L, Wang P, Zhang H, Chen Q, Cao Y, Liu X, Wang X. Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+/CaMKII-mTOR-NF-κB activation. Biomed. Pharmacother. 2022 Sep;153:113292. DOI: 10.1016/j.biopha.2022.113292Yoon SH, Hwang I, Lee E, Cho HJ, Ryu JH, Kim TG, Yu JW. Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner. J. Invest. Dermatol. 2021 Dec;141(12):2885–2894.e5. DOI: 10.1016/j.jid.2021.02.745Yoon SH, Hwang I, Lee E, Cho HJ, Ryu JH, Kim TG, Yu JW. Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner. J. Invest. Dermatol. 2021 Dec;141(12):2885–2894.e5. DOI: 10.1016/j.jid.2021.02.745Bowe WP, Joshi SS, Shalita AR. Diet and acne. J. Am. Acad. Dermatol. 2010 Jul;63(1):124–41. DOI: 10.1016/j.jaad.2009.07.043Bowe WP, Joshi SS, Shalita AR. Diet and acne. J. Am. Acad. Dermatol. 2010 Jul;63(1):124–41. DOI: 10.1016/j.jaad.2009.07.043Tanghetti EA. The role of inflammation in the pathology of acne. J. Clin. Aesthet. Dermatol. 2013 Sep;6(9):27–35.Tanghetti EA. The role of inflammation in the pathology of acne. J. Clin. Aesthet. Dermatol. 2013 Sep;6(9):27–35.Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch. Dermatol. Res. 2019 Jul;311(5):337–349. DOI: 10.1007/s00403–019–01908-xCong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch. Dermatol. Res. 2019 Jul;311(5):337–349. DOI: 10.1007/s00403–019–01908-xGollnick HP. From new findings in acne pathogenesis to new approaches in treatment. J. Eur. Acad. Dermatol. Venereol. 2015 Jun;29 Suppl 5:1–7. DOI: 10.1111/jdv.13186.Gollnick HP. From new findings in acne pathogenesis to new approaches in treatment. J. Eur. Acad. Dermatol. Venereol. 2015 Jun;29 Suppl 5:1–7. DOI: 10.1111/jdv.13186.Kircik LH. What’s new in the management of acne vulgaris. Cutis. 2019 Jul;104(1):48–52. PMID: 31487336.Kircik LH. What’s new in the management of acne vulgaris. Cutis. 2019 Jul;104(1):48–52. PMID: 31487336.Snodgrass RG, Huang S, Choi IW, Rutledge JC, Hwang DH. Inflammasome-mediated secretion of IL-1β in human monocytes through TLR 2 activation; modulation by dietary fatty acids. J. Immunol. 2013 Oct 15;191(8):4337–47. DOI: 10.4049/jimmunol.1300298Snodgrass RG, Huang S, Choi IW, Rutledge JC, Hwang DH. Inflammasome-mediated secretion of IL-1β in human monocytes through TLR 2 activation; modulation by dietary fatty acids. J. Immunol. 2013 Oct 15;191(8):4337–47. DOI: 10.4049/jimmunol.1300298Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KG, Watkins BA. Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J. Bone. Miner. Res. 1999 Jul;14(7):1153–62. DOI: 10.1359/jbmr.1999.14.7.1153Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KG, Watkins BA. Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J. Bone. Miner. Res. 1999 Jul;14(7):1153–62. DOI: 10.1359/jbmr.1999.14.7.1153Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin. Cosmet. Investig. Dermatol. 2015 Jul 15;8:371–88. DOI: 10.2147/CCID.S 69135Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin. Cosmet. Investig. Dermatol. 2015 Jul 15;8:371–88. DOI: 10.2147/CCID.S 69135Sansone A, Tolika E, Louka M, Sunda V, Deplano S, Melchiorre M, Anagnostopoulos D, Chatgilialoglu C, Formisano C, Di Micco R, Faraone Mennella MR, Ferreri C. Hexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles. PLoS One. 2016 Apr 5;11(4): e0152378. DOI: 10.1371/journal.pone.0152378Sansone A, Tolika E, Louka M, Sunda V, Deplano S, Melchiorre M, Anagnostopoulos D, Chatgilialoglu C, Formisano C, Di Micco R, Faraone Mennella MR, Ferreri C. Hexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles. PLoS One. 2016 Apr 5;11(4): e0152378. DOI: 10.1371/journal.pone.0152378Scanferlato R, Bortolotti M, Sansone A, Chatgilialoglu C, Polito L, De Spirito M, Maulucci G, Bolognesi A, Ferreri C. Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells. Int J. Mol. Sci. 2019 Feb 15;20(4):832. DOI: 10.3390/ijms20040832.Scanferlato R, Bortolotti M, Sansone A, Chatgilialoglu C, Polito L, De Spirito M, Maulucci G, Bolognesi A, Ferreri C. Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells. Int J. Mol. Sci. 2019 Feb 15;20(4):832. DOI: 10.3390/ijms20040832.Jung JY, Kwon HH, Hong JS, Yoon JY, Park MS, Jang MY, Suh DH. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial. Acta. Derm. Venereol. 2014 Sep;94(5):521–5. DOI: 10.2340/00015555–1802Jung JY, Kwon HH, Hong JS, Yoon JY, Park MS, Jang MY, Suh DH. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial. Acta. Derm. Venereol. 2014 Sep;94(5):521–5. DOI: 10.2340/00015555–1802Park KY, Ko EJ, Kim IS, Li K, Kim BJ, Seo SJ, Kim MN, Hong CK. The effect of evening primrose oil for the prevention of xerotic cheilitis in acne patients being treated with isotretinoin: a pilot study. Ann Dermatol. 2014 Dec;26(6):706–12. DOI: 10.5021/ad.2014.26.6.706Park KY, Ko EJ, Kim IS, Li K, Kim BJ, Seo SJ, Kim MN, Hong CK. The effect of evening primrose oil for the prevention of xerotic cheilitis in acne patients being treated with isotretinoin: a pilot study. Ann Dermatol. 2014 Dec;26(6):706–12. DOI: 10.5021/ad.2014.26.6.706Krishna S, Okhovat JP, Kim J, Kim CN. Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. JAMA Dermatol. 2015 Jan;151(1):101–2. DOI: 10.1001/jamadermatol.2014.2402Krishna S, Okhovat JP, Kim J, Kim CN. Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. JAMA Dermatol. 2015 Jan;151(1):101–2. DOI: 10.1001/jamadermatol.2014.2402Parmentier M., Mahmoud C. A.S., Linder M., Fanni J. Polar lipids: N-3 PUFA carriers for membranes and brain: Nutritional interest and emerging processes. Oléagineux Corps gras Lipides 2007;14:224–229. DOI: 10.1051/ocl.2007.0127Parmentier M., Mahmoud C. A.S., Linder M., Fanni J. Polar lipids: N-3 PUFA carriers for membranes and brain: Nutritional interest and emerging processes. Oléagineux Corps gras Lipides 2007;14:224–229. DOI: 10.1051/ocl.2007.0127Hernandez E. M. 4-Specialty Oils: Functional and Nutraceutical Properties. In Functional Dietary Lipids: Food Formulation, Consumer Issues and Innovation for Health; Sanders, T., Ed.; Woodhead Publishing-Elsevier: Cambridge, UK, 2016; pp. 69–101.Hernandez E. M. 4-Specialty Oils: Functional and Nutraceutical Properties. In Functional Dietary Lipids: Food Formulation, Consumer Issues and Innovation for Health; Sanders, T., Ed.; Woodhead Publishing-Elsevier: Cambridge, UK, 2016; pp. 69–101.Saini R. K., Shetty N. P., Giridhar P. GC-FID/MS Analysis of Fatty Acids in Indian Cultivars of Moringa oleifera: Potential Sources of PUFA. J. Am. Oil Chem. Soc. 2014;91:1029–1034.Saini R. K., Shetty N. P., Giridhar P. GC-FID/MS Analysis of Fatty Acids in Indian Cultivars of Moringa oleifera: Potential Sources of PUFA. J. Am. Oil Chem. Soc. 2014;91:1029–1034.Saini R. K., Shang X. M., Ko E. Y., Choi J. H., Kim D., Keum Y.-S. Characterization of nutritionally important phytoconstituents in minimally processed ready-to-eat baby-leaf vegetables using HPLC–DAD and GC–MS. J. Food Meas. Charact. 2016;10:341–349.Saini R. K., Shang X. M., Ko E. Y., Choi J. H., Kim D., Keum Y.-S. Characterization of nutritionally important phytoconstituents in minimally processed ready-to-eat baby-leaf vegetables using HPLC–DAD and GC–MS. J. Food Meas. Charact. 2016;10:341–349.Harwood J. L. Algae: Critical sources of very long-chain polyunsaturated fatty acids. Biomolecules. 2019;9:708.Harwood J. L. Algae: Critical sources of very long-chain polyunsaturated fatty acids. Biomolecules. 2019;9:708.Prokopenko E. V., Orlova S. V., Nikitina E. A. Algae and omega 3 PUFAs. Medical alphabet. 2022;(16):93–101. DOI: 10.33667/2078–5631–2022–16–93–101Prokopenko E. V., Orlova S. V., Nikitina E. A. Algae and omega 3 PUFAs. Medical alphabet. 2022;(16):93–101. DOI: 10.33667/2078–5631–2022–16–93–101

The authors declare that there are no conflicts of interest present.